Halliday, G. M., Ophof, A., Broe, M.
, Jensen, P. H., Kettle, E., Fedorow, H., Cartwright, M. I., Griffiths, F. M., Shepherd, C. E. & Double, K. L. (2005).
α-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson’s disease.
Brain,
128, 2654-2664.
Ghanem, S. S., Majbour, N. K., Vaikath, N. N., Ardah, M. T., Erskine, D.
, Jensen, N. M., Fayyad, M., Sudhakaran, I. P., Vasili, E., Melachroinou, K., Abdi, I. Y., Poggiolini, I., Santos, P., Dorn, A., Carloni, P., Vekrellis, K., Attems, J., McKeith, I., Outeiro, T. F. ... El-Agnaf, O. M. A. (2022).
α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity.
Proceedings of the National Academy of Sciences (PNAS),
119(15), Article e2109617119.
https://doi.org/10.1073/pnas.2109617119
Delaidelli, A.
, Richner, M., Jiang, L., van der Laan, A., Bergholdt Jul Christiansen, I., Ferreira, N., Nyengaard, J. R., Vægter, C. B., Jensen, P. H., Mackenzie, I. R., Sorensen, P. H.
& Jan, A. (2021).
α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response.
Acta Neuropathologica Communications,
9(1), Article 105.
https://doi.org/10.1186/s40478-021-01209-3
Stokholm, K., Thomsen, M. B., Phan, J. A., Møller, L. K.
, Bay-Richter, C., Christiansen, S. H., Woldbye, D. P. D.
, Romero-Ramos, M. & Landau, A. M. (2021).
α-Synuclein Overexpression Increases Dopamine D2/3 Receptor Binding and Immune Activation in a Model of Early Parkinson’s Disease.
Biomedicines,
9(12), Article 1876.
https://doi.org/10.3390/biomedicines9121876
Lindersson, E., Højrup, P., Gai, W.-P., Locker, D., Martin, D.
& Jensen, P. H. (2004).
α-synuclein filaments bind the transcriptional activator HMGB-1.
J Neuroreport,
15, 2735-2739.
Febbraro, F., Giorgi, M., Caldarola, S., Loreni, F.
& Romero-Ramos, M. (2012).
α-Synuclein expression is modulated at the translational level by iron.
NeuroReport,
23(9), 576-80.
https://doi.org/10.1097/WNR.0b013e328354a1f0
Kragh, C. L., Lund, L. B., Febbraro, F., Hansen, H. D., Gai, W. P., Richter-Landsberg, C.
& Jensen, P. H. (2009).
α-synuclein aggregation and Ser129 phosphorylation dependent cell death in oligodendroglial cells. Journal of Biological Chemistry,
284, 10211-10222.
van Rijt, W. G.
, Secher, N., Keller, A. K., Møldrup, U., Chynau, Y., Ploeg, R. J., van Goor, H.
, Nørregaard, R., Birn, H., Frøkiaer, J., Nielsen, S., Leuvenink, H. G. D.
& Jespersen, B. (2014).
α-Melanocyte Stimulating Hormone Treatment in Pigs Does Not Improve Early Graft Function in Kidney Transplants from Brain Dead Donors.
PLOS ONE,
9(4), e94609.
https://doi.org/10.1371/journal.pone.0094609
Mahía, A., Kiib, A. E., Nisavic, M., Svenningsen, E. B., Palmfeldt, J. & Poulsen, T. B. (2023).
α-Lactam Electrophiles for Covalent Chemical Biology.
Angewandte Chemie - International Edition,
62(26), Article e202304142.
https://doi.org/10.1002/anie.202304142
Johnsen, N., Hamilton, A. D. M., Greve, A. S., Christensen, M. G., Therkildsen, J. R., Wehmöller, J., Skals, M. & Praetorius, H. A. (2019).
α-Haemolysin production, as a single factor, causes fulminant sepsis in a model of Escherichia coli-induced bacteraemia.
Cellular Microbiology,
21(6), Article e13017.
https://doi.org/10.1111/cmi.13017
Christensen, H. M.
, Frystyk, J., Faber, J., Schou, M.
, Flyvbjerg, A., Hildebrandt, P., Raymond, I. E., Klausen, T. W. & Kistorp, C. M. N. (2012).
α-Defensins and outcome in patients with chronic heart failure.
European Journal of Heart Failure,
14(4), 387-94.
https://doi.org/10.1093/eurjhf/hfs021
Doganli, C., Beck, H. C., Ribera, A. B.
, Oxvig, C. & Lykke-Hartmann, K. (2013).
α3Na+/K+-ATPase deficiency causes brain ventricle dilation and abrupt embryonic motility in zebrafish.
Journal of Biological Chemistry,
288, 8862-8874.
https://doi.org/10.1074/jbc.M112.421529
Nørholt, S. E., Sköldstam, J., Blomlöf, J., Karunahara, S.
& Pedersen, T. K. (2022).
Zygomatic repositioning and Le Fort II distraction with intraoral devices in Apert syndrome: A case report: A case report.
Journal of Cranio-Maxillofacial Surgery,
50(4), 364-370.
https://doi.org/10.1016/j.jcms.2022.02.010
Thim, T., Maeng, M., Kaltoft, A., Jensen, L. O.
, Tilsted, H.-H., Hansen, P. R., Kelbaek, H., Thayssen, P.
, Ravkilde, J., Madsen, M., Sørensen, H. T., Thuesen, L. & Lassen, J. F. (2012).
Zotarolimus-eluting vs. sirolimus-eluting coronary stents in patients with and without acute coronary syndromes: a SORT OUT III substudy.
European Journal of Clinical Investigation,
42(10), 1047-1054.
https://doi.org/10.1111/j.1365-2362.2012.02692.x
Mæng, M., Holm, N. R., Kaltoft, A., Jensen, L. O.
, Hansen, H.-H. T., Thuesen, L. & Lassen, J. F. (2010).
Zotarolimus-eluting versus sirolimus-eluting coronary stent implantation.
Interventional Cardiology,
2(6), 208-12.
https://doi.org/10.2217/ica.10.72
Raungaard, B., Jensen, L. O.
, Tilsted, H.-H., Christiansen, E. H., Maeng, M., Terkelsen, C. J., Krusell, L. R., Kaltoft, A., Kristensen, S. D., Bøtker, H. E., Thuesen, L., Aarøe, J., Jensen, S. E., Villadsen, A. B., Thayssen, P., Veien, K. T., Hansen, K. N., Junker, A.
, Madsen, M. ... for the Scandinavian Organization for Randomized Trials with Clinical Outcome (SORT OUT) (2015).
Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial.
Lancet,
385(9977), 1527–1535.
https://doi.org/10.1016/S0140-6736(14)61794-3
Jõgi, N. O., Svanes, C., Siiak, S. P., Logan, E., Holloway, J. W., Igland, J., Johannessen, A., Levin, M., Real, F. G.
, Schlunssen, V., Horsnell, W. G. C. & Bertelsen, R. J. (2018).
Zoonotic helminth exposure and risk of allergic diseases: A study of two generations in Norway.
Clinical and Experimental Allergy,
48(1), 66-77.
https://doi.org/10.1111/cea.13055
Jogi, N. O., Siiak, S. P., Logan, E.
, Schlunssen, V., Svanes, C., Holloway, J. W., Bertelsen, R. J. & Horsnell, W. (2017).
Zoonotic exposure to helminths is associated with allergic sensitization in a Norwegian population.
European Respiratory Journal,
50(Suppl 61), Article PA4055.
https://doi.org/10.1183/1393003.congress-2017.PA4055
Agger, J. F., Miazi, O. F., Christoffersen, AB., Agerholm, J. S., Villumsen, S., Kantsø, B.
, Bosnjak, E. & Nielsen, H. I. (2011).
Zoonotic aspects of Coxiella burnetii antibody positivity between dairy cattle herds and their farmers. Poster session presented at International Meeting on Emerging Diseases and Surveillance, Wien, Austria.
Agger, J. F., Miazi, O. F., Christoffersen, AB., Agerholm, J. S., Villumsen, S., Kantsø, B.
, Bosnjak, E. & Nielsen, H. I. (2011).
Zoonotic aspects of Coxiella burnetii antibody positivity between dairy cattle herds and their farmers. Abstract from International Meeting on Emerging Diseases and Surveillance, Wien, Austria.
Reimers, A., Helde, G., Becser Andersen, N., Aurlien, D., Surlien Navjord, E., Haggag, K.
, Christensen, J., Lillestølen, K. M., Nakken, K. O. & Brodtkorb, E. (2018).
Zonisamide serum concentrations during pregnancy.
Epilepsy Research,
144, 25-29.
https://doi.org/10.1016/j.eplepsyres.2018.05.002
Lima, W., Parreira, K., Devuyst, O., Caplanusi, A., N´Kuli, F., Van Der Smissen, P., Alves, P., Verroust, P.
, Christensen, E. I., Terzi, F., Matter, K., Pierreux, M. & Courtoy, P. (2010).
ZONAB is regulated during cell polarization and represses apical differentiation.
Journal of the American Society of Nephrology,
21, 478-488.
Kiss, A.
, Søderman, A., Bundzikova, J., Pirnik, Z. & Mikkelsen, J. (2006).
Zolpidem, a selective GABA(A) receptor alpha1 subunit agonist, induces comparable Fos expression in oxytocinergic neurons of the hypothalamic paraventricular and accessory but not supraoptic nuclei in the rat. Brain. Res. Bull.,
71(1-3), 200-2007.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Citation&list_uids=17113947
Wendelboe, M. H.
, Thomsen, J. S., Henriksen, K.
, Vegger, J. B. & Brüel, A. (2016).
Zoledronate prevents lactation induced bone loss and results in additional post-lactation bone mass in mice.
Bone,
87, 27-36.
https://doi.org/10.1016/j.bone.2016.03.012
Granild-Jensen, J. B., Møller-Madsen, B., Rackauskaite, G., Farholt, S., Søndergaard, C., Sørensen, T. H., Vestergaard, E. T. & Langdahl, B. L. (2023).
Zoledronate increases bone mineral density in non-ambulant children with cerebral palsy: A randomized, controlled trial.
Developmental Medicine and Child Neurology,
65(S2), 67.
https://doi.org/10.1111/dmcn.15595
Granild-Jensen, J. B., Møller-Madsen, B., Rackauskaite, G., Farholt, S., Søndergaard, C., Sørensen, T. H.
, Vestergaard, E. T. & Langdahl, B. L. (2023).
Zoledronate increases bone mineral density in non-ambulant children with cerebral palsy: A randomized, controlled trial.
The Journal of Clinical Endocrinology & Metabolism,
108(11), 2840-2851.
https://doi.org/10.1210/clinem/dgad299
Granild-Jensen, J. B., Møller-Madsen, B., Rackauskaite, G., Farholt, S., Søndergaard, C., Vestergaard, E. T. & Langdahl, B. L. (2023).
Zoledronate increases Bone Mineral Density in children with severe cerebral palsy: A randomized, controlled trial. 91.
Sørensen, J. S., Sani, F., Flemming, P., Ellermann, A., Kurt, K., Kjærsgård, P.
& Birkebæk, N. (2009).
ZnT8, GAD 65 and IA-2 autoantibodies in type 1 diabetes children at diagnosis and 3-5 years after the diagnosis, stratified for residual beta cell function.
Hormone Research, (Suppl 3), 53.
Sørensen, J. S., Vaziri-Sani, F., Pociot, F.
, Kristensen, K., Brorsson, C., Lyngssø, L., Dolmer, B.
& Birkebæk, N. (2010).
ZnT8 autoantibody specificities at, and 3-5 years after clinical onset, associates with the age at diagnosis and the SLC30A8 gene polymorphism in Danish children.
Pediatric Diabetes,
11(Suppl 14):24.
Tillmann, S., Pereira, V. S., Liebenberg, N., Christensen, A. K. & Wegener, G. (2017).
ZL006, a small molecule inhibitor of PSD-95/nNOS interaction, does not induce antidepressant-like effects in two genetically predisposed rat models of depression and control animals.
P L o S One,
12(8), 1-17. Article e0182698.
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0182698
Egefjord, L., Jensen, J., Bang-Berthelsen, C.
, Petersen, A. B., Smidt, K., Schmitz, O., Karlsen, A. E., Pociot, F., Chimienti, F.
, Rungby, J. & Magnusson, N. (2009).
Zinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in beta-cell apoptosis? B M C Endocrine Disorders,
9(1), 7.
https://doi.org/10.1186/1472-6823-9-7
Chi, Z.-H., Wang, X., Cai, J.-Q.
, Stoltenberg, M., Danscher, G. & Wang, Z.-Y. (2008).
Zinc transporter 3 immunohistochemistochemical tracing of sprouting mossy fibres.
Neurochemistry International,
52(7), 1305-1309.